新冠疫情期间的禁闭对帕金森病患者的焦虑和抑郁没有影响。
No impact of confinement during COVID-19 pandemic on anxiety and depression in Parkinsonian patients.
机构信息
Neurology Department, Ibn Rochd Hospital, Casablanca, Morocco; Genetics and Molecular Biology Laboratory; Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco.
Neurology Department, Ibn Rochd Hospital, Casablanca, Morocco; Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco.
出版信息
Rev Neurol (Paris). 2021 Mar;177(3):272-274. doi: 10.1016/j.neurol.2021.01.005. Epub 2021 Feb 11.
BACKGROUND
Governments around the world have imposed varied containment measures to curb the spread of the COVID-19 infection. The psychological impact could be highly negative in patients with neurologic condition like Parkinson's Disease (PD).
METHODS
We prospectively evaluated symptoms of depression and anxiety in 50 (26 females; mean age at 60.4) non demented Moroccan PD patients, using Hospital Anxiety and Depression Scale (HADS), at the beginning and after 6 weeks of a full confinement.
RESULTS
At the first evaluation, 28% of patients had depression while 32% had anxiety. After 6 weeks of confinement, some patients got worse and others got better scores but no significant statistical difference for both troubles was seen.
CONCLUSION
Our results show that there is no significant impact of 6 weeks of confinement on overall anxiety and depression scores. However, confinement could have an unexpected positive psychological impact on a significant number of PD patients.
背景
为了遏制 COVID-19 感染的传播，世界各地的政府都实施了各种遏制措施。对于患有帕金森病（PD）等神经疾病的患者，这可能会对其心理产生极大的负面影响。
方法
我们前瞻性地评估了 50 名（26 名女性；平均年龄 60.4 岁）非痴呆的摩洛哥 PD 患者在完全隔离 6 周前后的抑郁和焦虑症状，使用医院焦虑和抑郁量表（HADS）进行评估。
结果
在第一次评估时，28%的患者有抑郁症状，32%的患者有焦虑症状。隔离 6 周后，一些患者的评分变差，而另一些患者的评分变好，但两种困扰都没有显著的统计学差异。
结论
我们的结果表明，6 周的隔离对总体焦虑和抑郁评分没有显著影响。然而，隔离可能会对相当数量的 PD 患者产生意想不到的积极心理影响。
Zotero 插件